| Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation | European journal of haematology |  | | 2011 | 686 | 0 |
|
| Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications | Blood | | | 2006 | 643 | 0 |
|
| Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation | Biology of blood and marrow transplantation | | | 2004 | 622 | 0 |
|
| Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells | Journal of cellular physiology | | | 2004 | 626 | 0 |
|
| Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes | European Journal of Immunology |  | | 2004 | 273 | 279 |
|
| Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors | Blood | | | 2003 | 311 | 328 |
|
| Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay | Journal of clinical microbiology | | | 2002 | 662 | 0 |
|
| Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells | British journal of haematology | | | 2002 | 165 | 485 |
|
| Fatal myocardial aspergillosis in an immunosuppressed child | Journal of pediatric hematology/oncology | | | 2001 | 591 | 0 |
|
